Correlation Between Mettler Toledo and Molecular Partners
Can any of the company-specific risk be diversified away by investing in both Mettler Toledo and Molecular Partners at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Mettler Toledo and Molecular Partners into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Mettler Toledo International and Molecular Partners AG, you can compare the effects of market volatilities on Mettler Toledo and Molecular Partners and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Mettler Toledo with a short position of Molecular Partners. Check out your portfolio center. Please also check ongoing floating volatility patterns of Mettler Toledo and Molecular Partners.
Diversification Opportunities for Mettler Toledo and Molecular Partners
-0.56 | Correlation Coefficient |
Excellent diversification
The 3 months correlation between Mettler and Molecular is -0.56. Overlapping area represents the amount of risk that can be diversified away by holding Mettler Toledo International and Molecular Partners AG in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Molecular Partners and Mettler Toledo is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Mettler Toledo International are associated (or correlated) with Molecular Partners. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Molecular Partners has no effect on the direction of Mettler Toledo i.e., Mettler Toledo and Molecular Partners go up and down completely randomly.
Pair Corralation between Mettler Toledo and Molecular Partners
Considering the 90-day investment horizon Mettler Toledo International is expected to under-perform the Molecular Partners. But the stock apears to be less risky and, when comparing its historical volatility, Mettler Toledo International is 3.64 times less risky than Molecular Partners. The stock trades about -0.06 of its potential returns per unit of risk. The Molecular Partners AG is currently generating about 0.05 of returns per unit of risk over similar time horizon. If you would invest 521.00 in Molecular Partners AG on September 15, 2024 and sell it today you would earn a total of 34.00 from holding Molecular Partners AG or generate 6.53% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Against |
Strength | Very Weak |
Accuracy | 100.0% |
Values | Daily Returns |
Mettler Toledo International vs. Molecular Partners AG
Performance |
Timeline |
Mettler Toledo Inter |
Molecular Partners |
Mettler Toledo and Molecular Partners Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Mettler Toledo and Molecular Partners
The main advantage of trading using opposite Mettler Toledo and Molecular Partners positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Mettler Toledo position performs unexpectedly, Molecular Partners can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Molecular Partners will offset losses from the drop in Molecular Partners' long position.Mettler Toledo vs. Molecular Partners AG | Mettler Toledo vs. MediciNova | Mettler Toledo vs. Anebulo Pharmaceuticals | Mettler Toledo vs. Shattuck Labs |
Molecular Partners vs. Puma Biotechnology | Molecular Partners vs. Iovance Biotherapeutics | Molecular Partners vs. Day One Biopharmaceuticals | Molecular Partners vs. Inozyme Pharma |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Sectors module to list of equity sectors categorizing publicly traded companies based on their primary business activities.
Other Complementary Tools
Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios |